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SUMMARY: Use of fibrin glue in the treatment of pilonidal sinus
disease: a pilot study.
R. PAT TI, M. ANGILERI, G. MIGLIORE, M. SPARACELLO,
S. TERMINE, F. CRIVELLO, F. P. GIOÈ, G. DI VITA
Background. Pilonidal sinus (PS) disease of the sacrococcigeal re-
gion is an acquired condition resulting from penetration of shed hair
shafts through the skin. Different types of operations have been descri-
bed in the letterature. More recently fibrin glue has been used with suc-
cesfull. Aim of this study was to assess the effectiveness of fibrin glue for
the treatment of pilonidal sinus.
Patients and methods. Eight patients age ranged 21,8 ± 6,5 af-
fected by PS disease of sacrococcigeal region were included in this study.
All patients undergoing surgical operation under local anaesthesia. Fol-
lowing administration of 1% methylene blue through the main ope-
ning, a small vertical elliptical incision is maked including the entire
sinus opening and an excision of PS was performed without entering
the sinus cavity, removing a minimal amount of subcutaneous tissue.
Afterwards the highly concentrated fibrin glue, containing 1,000 U/ml
of thrombin was applied to cover the wound. Post-operative pain, anal-
gesic consumption, duration of hospital stay, failure healing, the rate
and time of recurrence, time to healing, time to return to work and po-
st-operative complications were recordered.
Results. All patients expressed satisfaction with the procedure.
Mean hospital stay was 5.4±2.1 hours. Healing was achieved after
25.8±13.2 days. The post-operative pain mean score was 3.8±2.1 in
first day, 2,9±1,8 in third day and 1,3±0,8 in the seventh day. The
mean analgesic consumption per week was 5,6±3,2 medications. Mean
time to return to work was 5,3±2,1 days.
Conclusion. The minimal excision of PS and application of fibrin
glue is a non-invasive effective treatment, easy and simple to performe
and not associated to recurrences. For these reasons this procedure in our
opinion as the first line treatment for pilonidal sinus disease.  
RIASSUNTO: L’uso della colla di fibrina nel trattamento del sinus
pilonidale: studio preliminare.
R. PAT TI, M. ANGILERI, G. MIGLIORE, M. SPARACELLO,
S. TERMINE, F. CRIVELLO, F. P. GIOÈ, G. DI VITA
Introduzione. Il sinus pilonidalis (PS) è una patologia acquisita
che deriva dalla inclusione di peli. Sono stati descritti in letteratura
differenti approcci terapeutici. Più recentemente è stata utilizzata con
successo la colla di fibrina. Lo scopo di questo studio è quello di valu-
tare l'efficacia della colla di fibrina nel trattamento del PS.
Pazienti e metodi. Sono stati inclusi in questo studio 8 pazienti,
di età media 21,8±6,5 anni, affetti da PS. Tutti i pazienti sono stati
sottoposti ad intervento chirurgico in anestesia locale. Dopo l'iniezio-
ne di blu di metilene all'1% attraverso l'orifizio cutaneo, è stata pra-
ticata un'escissione del PS, senza entrare in cavità, comprendente una
piccola pastiglia cutanea ed una minima quantità di tessuto sottocu-
taneo. Successivamente è stata applicata nella ferita colla di fibrina ad
alta concentrazione, contenente 1,000 U/ml di trombina. Sono stati
valutati il dolore post-operatorio, il consumo di analgesici, la durata
del ricovero, la mancata guarigione, il tempo di guarigione, il tasso e
il tempo di comparsa della recidiva, il tempo di ripresa dell'attività la-
vorativa e le complicanze post-operatorie.
Risultati. Tutti i pazienti sono rimasti soddisfatti della procedura.
Il ricovero ospedaliero è stato in media di 5,4±2,1 ore, il punteggio me-
dio del dolore post-operatorio è stato 3,8±2,1 in prima giornata,
2,9±1,8 in terza giornata e 1,3±0,8 in settima giornata, il consumo set-
timanale di analgesici è stato di 5,6±3,2 somministrazioni. Il tempo di
ripresa dell'attività lavorativa è stato in media di 5,3±2,1 giorni.
Conclusioni. L'escissione del PS, comprendente una minima quo-
ta di tessuto sottocutaneo, e l'applicazione di colla di fibrina è un trat-
tamento non invasivo, di facile e semplice esecuzione e risolutivo. Per
queste ragioni tale procedura può essere considerata il trattamento di
prima scelta del PS.
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Introduction
Pilonidal sinus (PS) disease is a common condition
affecting tipically young male patients after puberty.
PS has widely been accepted as an acquired condition
that results from the penetration of shed hair shafts th-
rough the skin (1).
Management of this disease remains controversial.
Many different types of operations have been descri-
bed in the literature: brushing or phenolization of the
track, simple incision and drainage, laying open, mar-
supialization, excision and open granulation, elliptical,
medial or paramedial excision and primary closure,
rhomboid excision and the flap procedure.
An ideal treatment should be simple, should requi-
re short or no hospital stay, should have a low recur-
rence rate, should be associated with minimal pain and
wound care, to decrease time off work (2), and should
be low cost with a good aesthetic results (3).
Recently fibrin glue has been used for the treat-
ment of PS with encouraging results. The advantage of
using fibrin glue is that healing of the track can be
achieved without excision of a large amount of tissue.
This study was designed to investigate the role of fi-
brin tissue glue as a minimal potential invasive treat-
ment for PS disease.
Patients and methods
This study includes 8 male patients who underwent surgery
for PS disease. Patients gave a written, informed consent and the
local ethical committee and the departmental internal review
board approved the study. The patients age was 21,8±6,5 years
(mean ± standard deviation), and a family history was present in
two of them. Sinuses with purulent discharge were considered acu-
te, sinuses that had serous leakage inactive disease previously in-
fected were considered chronic. The mean period of time during
patients had symptoms was 9,5±13,8 months. Five sinuses were
acute, the mean number of sinuses opening was 2±1. The direction
of sinuses was cephalad for five patients, caudate for two and both
for one patient. The exclusion criteria in this study were: patients
with a very large cavity and with acute abscess; small inactive PS
disease previously not infected; number of the tracts more than th-
ree; sinus extending lateral to the anal cleft and orifice near to the
anus; recurrent disease. 
All patient received a single intravenous dose of ceftazidine
and metronidazole and were operated on under local anaesthesia.
The natal cleft was shaved the day before the surgery. The patients
were placed in prone jack-knife position on the operating table
with the legs slightly abduced and with a pillow under the pelvis
to elevate it. The buttocks strapped apart by adhesive tapes on the
table. Local anaesthesia is achieved by infiltration of about 20 ml
of 0,5 bupivacaine around the PS. 
Following administration of 1% methylene blue through the
main opening, a small vertical elliptical incision is maked inclu-
ding the entire sinus opening, and an excision of PS was performed
without entering the sinus cavity, removing a minimal amount of
subcutaneous tissue. When are present two or more fistulous orifi-
ces, some small and separated elliptical incisions were performed.
The highly concentrated fibrin glue (Tissucol®, Baxter, Vienna),
containing 1,000 U/ml of thrombin was used. The thrombin and
activating factors, each in a separate container, were then aspired
into a double-armed syringe attached to a soft triple lumen cathe-
ter; the third one for the air was not used in the study. After that
the stretched buttocks are released, the fibrin glue was injected si-
multaneously slowly with drawing the catheter. Gause is applied to
cover the wound to prevent water coming into contact with the fi-
brin glue. 
The duration of hospital stay, the post-operative pain, the
analgesic consumption, the failure healing, the rate and time of re-
currence, the healing time, time to return to work and the post-
operative complications (infection, oedema) were recordered. The
term “recurrence” was used when symptoms of the disease reap-
peared after an interval following complete wound healing. Any
wound that did not heal despite aggressive wound care was ac-
cepted as a “healing failure” rather than “disease recurrence”.
“Healing time” was defined as the period from the date of the
operation to the date when the wound was completely closed.
The time of incapacity to work was defined as the time from the
date of surgery to the date on which the patient returned to nor-
mal activities including employment and leisure activities. A vi-
sual analogic scale from 0 to 10 was used to evaluate pain where
0 corrisponded to no pain and 10 to the worse conceivable pain.
The assessment of pain was made 1st ,2nd and 7th day after opera-
tion. The analgesic consumption was evaluated up to the seventh
day. All patients are reviewed in the ambulatory after two, five e
seven days and then weekly until the wound had healed and the-
re after every four months for one year.
It was recommended that they had to bath at least five times a
week and they had to depilate on the operation site monthly using
a depilatory cream starting after healing. We encouraged the pa-
tients to return to their normal activity as soon as possible becau-
se it was reported that the wounds healed more quickly in those
patients who resumed their normal routine before the closure of
the wound (4). All patients were advised thoroughly to contact our
out-clinic if any problems would appear from or in the operated
region during the appointments after fully healed.
Results
All patients were discharged on the same day after
surgery. The mean lenght of hospital stay was 5,4±2,1
hours. The amount of fibrin glue was 1,9±0,6 ml/L.
The medication number in hospital were 5,2±3,1. 
Wound infection or failure of healing was not ob-
served in any patients. Healing was achieved after
25,8±13,2 day. Only a patient had a breakdown of the
fibrin glue at the outpatient visit and was managed
with a second application of fibrin glue.
The postoperative pain mean score was 3,8±2,1 in
first day, 2,9±1,8 in third day and 1,3±0,8 in the se-
venth day. The mean analgesic consumption per week
was 5,6±3,2 medications. Time to return to work was
5,3±2,1 days. All patients during follow-up practised
at least five showers a week and they used monthly a
depilatory cream. There has been no recurrence in any
of the patients at follow-up.
All patients expressed satisfaction with the proce-
dure.
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Conclusion
There are two conflictual theories of pathogenesis.
They have both implications for the extent of surgical
resection thought necessary to achieve a cure. From
the end of the 1st century to the beginning of the 20th
century, the disease was studied on an embryologic ba-
sis by many authors who considered it of congenital
origin (5). On the basis of this hypotesis thus the ra-
dical removal of all tissue overlying the sacrum in or-
der to remove all embryologic remnants should not be
regarded as essential to treatment (6). Patey and Scarf,
soon after the end of World War II, hypothesized that
the disease was acquired by the penetration of hair in-
to subcutaneous tissue, with consequent granuloma-
tous reaction (7). They introduced this concept based
on the high incidence of recurrence after complete ex-
cision of all tissue overlying the sacrum and on the oc-
currence of the disease in other locations of the body
(7). On the basis of this theory, it has been proposed
the incision and curettage as method of choise to treat
the disease (5). This operation consists of exeresis of
the granulomatous tissue that contains the hair re-
sponsible for the above-mentioned reaction. Accor-
ding to Karydakis, three main factors play a part in the
hair insertion process: 1) the invader, consisting of loo-
se hair, 2) some force, which causes hair insertion, and
3) the vulnerability of the skin (8). If these three main
factors occur, then hair insertion and PS results. Thus,
for treatment and prevention of PS, these causative
factors must be eliminated (8). 
With the recognition that pilonidal disease is an ac-
quired lesion rather than a congenital abnormality,
this treatment has progressively become less invasive
and less aggressive (1). Armstrong and Barcia training
a conservative treatment, no excisional with meticu-
lous hair control by natal cleft shaving, improved peri-
neal hygiene, and limited lateral incision have had
good results (9). Limited excision of the fistulous tract
and their wounds were left opened for secondary in-
tention healing and represents one of the best thera-
peutic options (10,11). The result of this method is
comparable with the more aggressive frequently used a
large excisional and a primary closure and it has the
advantage of having a shorter convalescence and better
patient satisfaction although time of healing is more
longer (10). 
Recently fibrin glue has been used extensively by
surgeons for the treatment of various conditions (12).
It acts by supporting angiogenesis, fibroblast prolifera-
tion and collagen production. Trying to reduce the
healing time and with the purpose to practise proce-
dures minimally invasive the fibrin glue was used to
treat the PS. The fibrin glue has been used for the fir-
st time after wide excision of sinus complex (13). Then
Greenberg et al. in 2004 combines a curved skin inci-
sion and elevation of thick skin flap, complete excision
of the sinus and all its extensions, approximation of
the flap back to its original place, and injection of 2-4
ml of fibrin glue through the original PS opening to
hill the dead space under the skin flap (14). Seleem
and Al-Hashemy in 2005 used fibrin glue after exci-
sion a minimal amount of skin and subcutaneous tis-
sue (15), while Lund and Leveson after excision of the
epithelium of the sinus (16).
The minimal excision with tension free and appli-
cation of fibrin glue that we use is non invasive treat-
ment and it result easy and simple to perform and it is
not associated to recurrent disease. It can be perfor-
med under local anaesthesia, it no require many medi-
cations and long hospital stay, minimal post-operative
disability and the operation may be performed by sur-
geons who are less experienced. It has a good aesthetic
result without any disfigured scars saving the natural
and deep shape anal cleft. The prophylaxis of recurrent
disease, as there are the previously anatomic-clinical
conditions, has to be granted to a personal local hy-
giene with frequent showers so that the skin soaking
induced by bacterium superposition can allow the pe-
netration of shed hair shafts in the fragile skin plane of
the anal cleft. Besides the depilation with cream or la-
ser (17) seems to be very important; infact the new
growth and the aumont of hair are important factors
to cause the recurrence desease because there is not PS
without hair (18). In conclusion this procedure is sug-
gested as the first-line treatment of patients with any
type of PS. Further randomized prospective studies
should be conducted to value the detailed role of fibrin
glue application for treatment of PS. 
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